Comparing two arsenic trioxide administration methods in APL therapy.

Jin Zhou, Ran Meng, Bao-feng Yang

Journal: Chinese medical journal 2004;117(9):1411-3

PMID: 15377438

Abstract

Address: Hematology Division, The First Clinical Medical College of Harbin Medical University, Harbin 150001, China. [email protected]

MeSH Terms: Antineoplastic Agents, Arsenic Trioxide, Arsenicals, Humans, Leukemia, Promyelocytic, Acute, Leukocytosis, Oxides

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.